Toshiba Develops DNA Chip

Dec 05, 2004

According to JCN Network, Toshiba Corporation has announced the development of a highly sensitive electrochemical DNA chip that is able to detect DNA at very low concentrations.
The new chip integrates complementary metal oxide semiconductor (CMOS) circuits, one of the most widely used semiconductor-circuit technologies, with its sensors. It is the latest addition to Toshiba's advanced line-up of DNA chips and related technologies, and immediate applications will include analysis of susceptibility to anticancer drugs and health monitoring for preventative identification of disease genesis.

Toshiba announced its first electrochemical DNA chip in October 2001, a device that used an original current detection method to support development of individual treatment regimes for patients infected with hepatitis C. Jointly developed with a team from the Graduate School of Pharmaceutical Sciences of Osaka University, led by Professor Junichi Azuma, the chip supports investigation of treatment efficacy and side effects for individual patients. This research covered six areas of illness: tuberculosis, digestive disorders, ademonia, hyperlipemia, cardiac arrest and cancer.

Also this year, Toshiba announced a DNA chip for patients with rheumatism, developed in collaboration with Professor Naoyuki Kamatani of Tokyo Women's Medical University. Based on genetic statistics, the new DNA chip can determine drug efficacy and the probabilities of side effects and complications for patients.

The company will demonstrate the development concept of its latest chip at SEMICON Japan 2004, one of Japan largest semiconductor industry events, which will take place at Makuhari Messe, Chiba Prefecture, from December 1 - 3, 2004.

Explore further: Skin icons can tap into promise of smartwatch

add to favorites email to friend print save as pdf

Related Stories

The promise and peril of nanotechnology

Mar 26, 2014

Scientists at Northwestern University have found a way to detect metastatic breast cancer by arranging strands of DNA into spherical shapes and using them to cover a tiny particle of gold, creating a "nano-flare" ...

SlipChip counts molecules with chemistry and a cell phone

Nov 18, 2013

(Phys.org) —In developing nations, rural areas, and even one's own home, limited access to expensive equipment and trained medical professionals can impede the diagnosis and treatment of disease. Many qualitative ...

Improved decoding of DNA for custom medical treatments

Nov 08, 2013

One day, doctors will be able to create custom medical treatment plans based on a patient's DNA, pinpointing the root of a patient's illness and making sure treatment will not cause a fatal allergic reaction. ...

New technology for bioseparation

Sep 17, 2013

Separating target molecules in biological samples is a critical part of diagnosing and detecting diseases. Usually the target and probe molecules are mixed and then separated in batch processes that require ...

Recommended for you

Skin icons can tap into promise of smartwatch

2 minutes ago

You have heard it before: smartwatches are cool wearables but critics remind us of the fact that their small size makes many actions cumbersome and they question how many people will really have them on their ...

Samsung phones cleared for US government use

53 minutes ago

Samsung Electronics Co. said Tuesday some of its Galaxy mobile devices were approved by the National Security Agency for use with classified U.S. government networks and data, a boost to the company's efforts to expand in ...

Amazon, Simon & Schuster sign book retail deal

2 hours ago

Amazon has reached a deal with American book publisher Simon & Schuster, the companies said, though the e-commerce giant remains at loggerheads with France's Hachette over e-book pricing.

User comments : 0